<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Panth KM</submitter><funding>Dutch Research Council (NWO)</funding><pagination>22198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4770595</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Matrix metalloproteinase-2 (MMP2) is important in tumorigenesis, angiogenesis and tumor invasion. In this study, we investigated if the Cy5-tagged small immuno protein targeting the catalytic domain of human MMP2 (aMMP2-SIP) detects MMP2 in tumors non-invasively. For this purpose, we generated MMP2 expressing (empty vector EV) and knock-down (KD) HT1080, U373 and U87 cells, which were injected subcutaneously in the lateral flank of NMRI-nu mice. Optical imaging (Optix MX2) performed at 0.5, 2, 4, 8, 24 and 48 hour post injection (h.p.i.) of Cy5 tagged aMMP2-SIP, indicated significantly lower tumor to background ratios at both 24 (P = 0.0090) and 48 h.p.i. (P &lt; 0.0001) for the U87 MMP2-KD compared to control tumors. No differences were found for HT1080 and U373 models. U87 MMP2-KD tumors ha</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity.</pubmed_title><pmcid>PMC4770595</pmcid><funding_grant_id>911-06-003</funding_grant_id><pubmed_authors>Panth KM</pubmed_authors><pubmed_authors>Losen M</pubmed_authors><pubmed_authors>Lieuwes NG</pubmed_authors><pubmed_authors>Weber M</pubmed_authors><pubmed_authors>Lambin P</pubmed_authors><pubmed_authors>van den Beucken T</pubmed_authors><pubmed_authors>Dubois LJ</pubmed_authors><pubmed_authors>Biemans R</pubmed_authors><pubmed_authors>Yaromina A</pubmed_authors></additional><is_claimable>false</is_claimable><name>In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity.</name><description>Matrix metalloproteinase-2 (MMP2) is important in tumorigenesis, angiogenesis and tumor invasion. In this study, we investigated if the Cy5-tagged small immuno protein targeting the catalytic domain of human MMP2 (aMMP2-SIP) detects MMP2 in tumors non-invasively. For this purpose, we generated MMP2 expressing (empty vector EV) and knock-down (KD) HT1080, U373 and U87 cells, which were injected subcutaneously in the lateral flank of NMRI-nu mice. Optical imaging (Optix MX2) performed at 0.5, 2, 4, 8, 24 and 48 hour post injection (h.p.i.) of Cy5 tagged aMMP2-SIP, indicated significantly lower tumor to background ratios at both 24 (P = 0.0090) and 48 h.p.i. (P &lt; 0.0001) for the U87 MMP2-KD compared to control tumors. No differences were found for HT1080 and U373 models. U87 MMP2-KD tumors ha</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Feb</publication><modification>2025-04-25T19:06:32.041Z</modification><creation>2019-03-27T02:10:07Z</creation></dates><accession>S-EPMC4770595</accession><cross_references><pubmed>26923459</pubmed><doi>10.1038/srep22198</doi></cross_references></HashMap>